You may yet be able to lean out without losing out, as a new drug could save GLP-1 users from the flat fate of “Ozempic butt.

In a clinical trial, an experimental antibody reduced lean-mass loss in people on a GLP-1 drug. Whether that improves health ...

A drug that promotes muscle mass could help retain lean body mass when using weight-loss jabs, a study has suggested.

The results of two phase 3 trials investigating Survodutide, a weight loss drug from Boehringer Ingelheim, suggest that the ...

Imagine spending thousands of dollars on weight-loss medication—only to discover months later that it doesn't work for your ...

Thinking about taking Ozempic but worried about losing too much muscle? New clinical trial data might point to a future where that’s no longer a concern. Regeneron Pharmaceuticals announced the ...

The enormous popularity of new weight-loss drugs often eclipses the downsides: the burden of weekly injections, rough ...

Some experts believe that anyone could benefit from GLP-1 medications, as the popular drugs have become more widespread and accessible. Others, however, warn that the decision to take the diabetes and ...

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero? Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a ...

The experimental medication del-brax reduced biological markers of FSHD disease activity in a Phase 1/2 clinical trial, meeting study goals.